VERICEL CORPORATION (VCEL) FY2026 YTD Q2 P&L / Income Statement

VERICEL CORPORATION (VCEL) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Contract with Customer, Sales Channel. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

145,882,000 US dollars

Cost of product sales

40,214,000 US dollars

Gross profit

105,668,000 US dollars

Total operating expenses

113,298,000 US dollars

Income (loss) from operations

negative 7,630,000 US dollars

Total other income

3,534,000 US dollars

Income before income taxes (calculated)

negative 4,096,000 US dollars

Net income (loss)

negative 4,096,000 US dollars

M A C I Implants and kits

121,904,000 US dollars

Biopsy kits - Directly to consumer

1,220,000 US dollars

Epicel - Directly to consumer

21,289,000 US dollars

Undisclosed (calculated)

1,469,000 US dollars

Selling, general and administrative

97,701,000 US dollars

Research and development

15,597,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.